Sa1371 - Multicenter Phase II Clinical Trial of Modified Folfirinox in Gemcitabine Refractory Pancreatic Cancer

Gastroenterology ◽

10.1016/s0016-5085(18)31302-7 ◽

2018 ◽

Vol 154 (6) ◽

pp. S-282

Author(s):

Huapyong Kang ◽

Moon Jae Chung ◽

Sang Hyub Lee ◽

Ho Gak Kim ◽

Kwang Hyuck Lee ◽

...

Keyword(s):

Pancreatic Cancer ◽

Clinical Trial ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Multicenter Phase ◽

Gemcitabine Refractory

Download Full-text

Phase II Clinical Trial to Evaluate the Efficacy and Safety of Activated T-Lymphocyte Cell Therapy in Gemcitabine Refractory Advanced Pancreatic Cancer

Gastroenterology ◽

10.1016/s0016-5085(11)62815-1 ◽

2011 ◽

Vol 140 (5) ◽

pp. S-679

Author(s):

Moon Jae Chung ◽

Jeong Youp Park ◽

Seungmin Bang ◽

Seung Woo Park ◽

Jae Bock Chung ◽

...

Keyword(s):

Pancreatic Cancer ◽

Clinical Trial ◽

Cell Therapy ◽

Phase Ii ◽

T Lymphocyte ◽

Advanced Pancreatic Cancer ◽

Phase Ii Clinical Trial ◽

Efficacy And Safety ◽

Gemcitabine Refractory ◽

Lymphocyte Cell

Download Full-text

Phase II clinical trial to evaluate the efficacy and safety of activated T-lymphocyte cell therapy in gemcitabine refractory advanced pancreatic cancer

Pancreatology ◽

10.1016/j.pan.2013.07.181 ◽

2013 ◽

Vol 13 (4) ◽

pp. S45

Author(s):

Moon Jae Chung ◽

Jeong Youp Park ◽

Seungmin Bang ◽

Seung Woo Park ◽

Jae Bock Chung ◽

...

Keyword(s):

Pancreatic Cancer ◽

Clinical Trial ◽

Cell Therapy ◽

Phase Ii ◽

T Lymphocyte ◽

Advanced Pancreatic Cancer ◽

Phase Ii Clinical Trial ◽

Efficacy And Safety ◽

Gemcitabine Refractory ◽

Lymphocyte Cell

Download Full-text

A Phase II clinical trial to compare the effectiveness of gemcitabine and nab-paclitaxel administered in combination with ATRA vs without ATRA in patients with locally advanced treatment-naïve pancreatic cancer

http://isrctn.com/ ◽

10.1186/isrctn11503604 ◽

2021 ◽

Author(s):

Hemant Kocher

Keyword(s):

Pancreatic Cancer ◽

Clinical Trial ◽

Phase Ii ◽

Locally Advanced ◽

Phase Ii Clinical Trial ◽

Advanced Treatment ◽

Treatment Naïve

Download Full-text

Induced chemotherapy plus consolidative chemoradiotherapy is an optimal regimen for locally advanced pancreatic cancer A single institutional prospective phase II clinical trial

Pancreatology ◽

10.1016/j.pan.2018.05.367 ◽

2018 ◽

Vol 18 (4) ◽

pp. S136

Author(s):

Wenhui Lou ◽

Lili Wu ◽

Yuhong Zhou

Keyword(s):

Pancreatic Cancer ◽

Clinical Trial ◽

Phase Ii ◽

Locally Advanced ◽

Advanced Pancreatic Cancer ◽

Phase Ii Clinical Trial ◽

Locally Advanced Pancreatic Cancer ◽

Prospective Phase ◽

Optimal Regimen

Download Full-text

A multicenter phase II clinical trial using dacarbazine and continuous infusion lnterleukin-2 for metastatic melanoma. Clinical data and immunomonitoring

Cancer ◽

10.1002/1097-0142(19950215)75:4<1038::aid-cncr2820750421>3.0.co;2-f ◽

1995 ◽

Vol 75 (4) ◽

pp. 1038-1044 ◽

Author(s):

Reinhard Dummer ◽

Günter Burg ◽

Martin E. Gore ◽

Barry W. Hancock ◽

Pierre J. Guillou ◽

...

Keyword(s):

Clinical Trial ◽

Continuous Infusion ◽

Metastatic Melanoma ◽

Phase Ii ◽

Clinical Data ◽

Phase Ii Clinical Trial ◽

Multicenter Phase

Download Full-text

Multicenter Phase II Clinical Trial of Isolated Lung Perfusion in Patients With Lung Metastases

The Annals of Thoracic Surgery ◽

10.1016/j.athoracsur.2019.02.071 ◽

2019 ◽

Vol 108 (1) ◽

pp. 167-174 ◽

Author(s):

Paul A.J. Beckers ◽

Michel I.M. Versteegh ◽

Thomas J. Van Brakel ◽

Jerry Braun ◽

Bart Van Putte ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Lung Metastases ◽

Lung Perfusion ◽

Phase Ii Clinical Trial ◽

Multicenter Phase ◽

Isolated Lung Perfusion ◽

Download Full-text

Abstract 4664: Result of TORI L-03, a randomized, multicenter phase II clinical trial of erlotinib (E) or E + fulvestrant (F) in previously treated advanced non-small cell lung cancer (NSCLC).

10.1158/1538-7445.am2013-4664 ◽

2013 ◽

Author(s):

Edward B. Garon ◽

Jill M. Siegfried ◽

Steven M. Dubinett ◽

Robert M. Elashoff ◽

David J. Park ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Clinical Trial ◽

Small Cell Lung ◽

Multicenter Phase ◽

Previously Treated

Download Full-text

Everolimus in combination with weekly paclitaxel and trastuzumab in patients (pts) with HER2-overexpressing metastatic breast cancer (MBC) with prior resistance to trastuzumab and taxanes: A multicenter phase II clinical trial.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.1013 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 1013-1013 ◽

Author(s):

F. Dalenc ◽

M. Campone ◽

P. Hupperets ◽

R. O'Regan ◽

C. Manlius ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Metastatic Breast ◽

Phase Ii Clinical Trial ◽

Weekly Paclitaxel ◽

Multicenter Phase

Download Full-text

Phase II Clinical Trial of 5-Fluorouracil, Trimetrexate, and Leucovorin (NFL) in Patients With Advanced Pancreatic Cancer

International Journal of Gastrointestinal Cancer ◽

10.1385/ijgc:34:2-3:079 ◽

2003 ◽

Vol 34 (2-3) ◽

pp. 079-086 ◽

Author(s):

Agustin A. Garcia ◽

Lawrence Leichman ◽

Joaquina Baranda ◽

Lalita Pandit ◽

Heinz-Josef Lenz ◽

...

Keyword(s):

Pancreatic Cancer ◽

Clinical Trial ◽

Phase Ii ◽

Advanced Pancreatic Cancer ◽

Phase Ii Clinical Trial

Download Full-text

Abstract No LB12: A prospective, multicenter phase II clinical trial using irreversible electroporation for the treatment of early stage HCC

Journal of Vascular and Interventional Radiology ◽

10.1016/j.jvir.2012.05.018 ◽

2012 ◽

Vol 23 (8) ◽

pp. 1114 ◽

Author(s):

R. Lencioni ◽

F. Izzo ◽

L. Crocetti ◽

V. Vilgrain ◽

M. Abdel-Rehim ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Early Stage ◽

Irreversible Electroporation ◽

Phase Ii Clinical Trial ◽

Multicenter Phase

Download Full-text